SoftOx Solutions AS — Share Issue/Capital Change 2021

Feb 16, 2021

SoftOx Solutions AS: National Prospectus registered and commencement of subscription period in the subsequent offering

SoftOx Solutions AS: National Prospectus registered and commencement of subscription period in the subsequent offering

Reference is made to the stock exchange announcements from SoftOx Solutions AS (the "Company") on 16 December 2020 regarding the successful completion of a private placement and the contemplated repair issue to be carried out.

The subsequent offering was approved by the Company's extraordinary general meeting on 4 January 2021 (the "Subsequent Offering").

For the purposes of the Subsequent Offering, the Company has prepared a national prospectus (the "Prospectus"). The Prospectus has today been registered in the Norwegian Register of Business Enterprises (Nw: Foretaksregisteret). The Prospectus will be published on 17 February 2021 prior to the start of the Subscription Period, and can be obtained electronically by downloading it from www.soft-ox.com, www.sb1markets.no, or by contacting the Company or SpareBank 1 Markets AS (the "Manager").

The Subsequent Offering comprises an offer of up to 181,818 new shares in the Company (the "Offer Shares") at an offer price of NOK 55 per Offer Share, which equals the subscription price in the Private Placement announced by the Company on 16 December 2020. Total gross proceeds will amount to approximately NOK 9,999,990 million if all the Offer Shares are allocated.

The Company will, subject to applicable securities laws, grant non-transferable subscription rights to subscribe for Offer Shares to shareholders in the Company as of close of trading on 16 December 2020 as registered in the Norwegian Central Securities Depository (the "VPS") on 18 December 2020 (the "Record Date") who were not allocated shares in the Private Placement and who are not resident in a jurisdiction where such offering would be unlawful, or for jurisdictions other than Norway, would require any filing, registration or similar action (the “Eligible Shareholders”). Eligible Shareholders will be granted 0.0279 Subscription Rights for each share held. Each Subscription Right will give the right to subscribe for one Offer Share. Over-subscription and subscription without Subscription Rights will be permitted.

The subscription period in the Subsequent Offering commences on 17 February 2021 at 09:00 hours and will expire on 3 March 2021 at 16:30 hours CET (the "Subscription Period").

In order to subscribe for shares, the Manager must receive a complete and duly signed subscription form within the end of the Subscription Period. Further instructions regarding the subscription procedure is available in the Prospectus. Subscription Rights not used to subscribe for Offer Shares prior to 16:30 hours on 3 March 2021 will have no value and will lapse without compensation to the holder.

Notifications of allocated Offer Shares and the corresponding subscription amount to be paid by each subscriber are expected to be distributed on or about 4 March 2021.

The payment for Offer Shares allocated to a subscriber falls due on 8 March 2021 (the "Payment Date"). Delivery of the Offer Shares to investors' VPS accounts is expected to take place on or about 15 March 2021.

In addition to the Subsequent Offering, the Board of Directors has resolved that up to 181,818 new shares will, subject to applicable prospectus requirements and available exemptions, be offered to eligible employees, the members of the board of directors and certain invited hired external consultants of the Company at the same subscription price as in the Private Placement and the Subsequent Offering. The shares offered to employees will be issued by the board of directors under the authorisation to issue shares granted by the general meeting on 4 January 2021.

SpareBank 1 Markets AS are acting as Manager in connection with the Subsequent Offering. Advokatfirmaet Wiersholm AS acts as legal advisor to as the Company in connection with the Subsequent Offering.

For more information regarding the Subsequent Offering, please refer to the Prospectus available from 17 February 2021 on the Company's website www.soft-ox.com.

For further information, please contact:

Geir Almås, CEO of SoftOx Solutions AS

Mail: ir@soft-ox.com

Mobile: +47 948 59 599

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth, Oslo) is a Norwegian

MedTech company based in Oslo with the aim of helping to combat major threats to

human health, namely the emergence of antimicrobial resistance (AMR), biofilm

infections in chronic wounds and the spread of viruses. For more information on

SoftOx, visit www.soft-ox.com